Analysts Set Henry Schein, Inc. (NASDAQ:HSIC) PT at $78.89

Shares of Henry Schein, Inc. (NASDAQ:HSIC - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the eleven research firms that are currently covering the company, MarketBeat reports. Five research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $78.89.

A number of equities research analysts have weighed in on the stock. UBS Group decreased their target price on shares of Henry Schein from $75.00 to $72.00 and set a "neutral" rating for the company in a research note on Wednesday, August 7th. StockNews.com raised Henry Schein from a "sell" rating to a "hold" rating in a research report on Thursday, November 7th. Evercore ISI upped their price target on shares of Henry Schein from $70.00 to $74.00 and gave the company an "in-line" rating in a research report on Tuesday, October 8th. Robert W. Baird dropped their price objective on shares of Henry Schein from $92.00 to $82.00 and set an "outperform" rating on the stock in a report on Wednesday, August 7th. Finally, Barrington Research reiterated an "outperform" rating and issued a $82.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th.

Insider Activity

In other news, COO Michael S. Ettinger sold 12,240 shares of the business's stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total value of $918,000.00. Following the transaction, the chief operating officer now owns 87,706 shares of the company's stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Lorelei Mcglynn sold 21,035 shares of the business's stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. This represents a 22.65 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 1.14% of the company's stock.

Institutional Investors Weigh In On Henry Schein

A number of hedge funds have recently bought and sold shares of HSIC. Virtu Financial LLC bought a new stake in Henry Schein during the third quarter worth approximately $239,000. TCW Group Inc. increased its position in shares of Henry Schein by 6.6% during the 3rd quarter. TCW Group Inc. now owns 26,368 shares of the company's stock valued at $1,922,000 after purchasing an additional 1,628 shares during the last quarter. Toronto Dominion Bank raised its holdings in Henry Schein by 68.3% during the 3rd quarter. Toronto Dominion Bank now owns 62,779 shares of the company's stock valued at $4,577,000 after buying an additional 25,474 shares during the period. M&T Bank Corp lifted its position in Henry Schein by 4.5% in the third quarter. M&T Bank Corp now owns 10,990 shares of the company's stock worth $802,000 after buying an additional 472 shares during the last quarter. Finally, Barclays PLC boosted its stake in Henry Schein by 6.9% during the third quarter. Barclays PLC now owns 286,475 shares of the company's stock worth $20,882,000 after buying an additional 18,458 shares during the period. Hedge funds and other institutional investors own 96.62% of the company's stock.

Henry Schein Stock Up 1.8 %

NASDAQ HSIC traded up $1.31 during mid-day trading on Friday, reaching $75.08. The stock had a trading volume of 3,384,461 shares, compared to its average volume of 1,394,213. The stock has a market cap of $9.36 billion, a PE ratio of 30.78, a price-to-earnings-growth ratio of 2.15 and a beta of 0.87. Henry Schein has a 1 year low of $63.67 and a 1 year high of $82.63. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a fifty day moving average price of $70.80 and a 200 day moving average price of $69.72.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its quarterly earnings data on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, beating the consensus estimate of $1.17 by $0.05. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.17 billion for the quarter, compared to analysts' expectations of $3.24 billion. During the same period last year, the firm posted $1.32 earnings per share. Henry Schein's revenue was up .4% compared to the same quarter last year. On average, research analysts expect that Henry Schein will post 4.78 earnings per share for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.